Particulars |
|
|
|
Company Name
| Marksans Pharma Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
45.32 |
B.V. (₹) |
25.70 |
Sales(₹ Cr.) |
655.20 |
NP (₹ Cr.) |
102.91 |
NP Var (%) |
-1.00 |
Div% |
50.00 |
CPS(₹) |
2.60 |
EPS (₹) |
2.30 |
Traded Value(₹ Lakhs) |
122.52 |
52 Week High |
185.00 |
52 Week Low |
70.00 |
Price BSE |
166.00 |
Price NSE |
166.00 |
Market Capital (₹ Cr.) |
7,531.58 |
P/C Ratio |
62.90 |
P/E Ratio |
73.10 |
Price Vs.BV |
6.46 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
241.36 |
NP(₹ Cr.) |
25.29 |
NP Var % |
-1.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
671.63 |
OPM |
14.90 |
NP |
106.92 |
NP Var (%) |
11.36 |
EPS |
2.62 |
PE |
63.44 |
|
|